ZU FASHAN: Open Payments
NPI 1255773321 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 7 payments from 4 companies in 2025. Trend: 2023 $415 · 2024 $1,178 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $163 |
| Otsuka America Pharmaceutical, Inc. | 2 | $138 |
| Alkermes, Inc. | 1 | $126 |
| Janssen Pharmaceuticals, Inc | 1 | $53 |
Products named: INGREZZA, LYBALVI, ABILIFY MAINTENA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
